Clinical trial

Impact of COVID-19 Vaccines on Cerebrovascular Health

NCT04992195

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention Laboratory tests and Montreal Cognitive Assessment Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Impact of COVID-19 Vaccines on Cerebrovascular Health

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2021-07-05

PhaseN/A

Conditions

Strokeverified · MONDO: stroke disorder

Stroke, Acuteunresolved

Stroke, Ischemiccandidate · MONDO: ischemic stroke

Dementiaverified · MONDO: dementia

Brain Ischemiaverified · MONDO: brain ischemia

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Brain Diseasesunresolved

Major Adverse Cardiovascular Eventunresolved

Arterial Thromboembolismunresolved

Venous Thromboembolismverified · MONDO: venous thromboembolism

Interventions

Laboratory tests and Montreal Cognitive AssessmentDIAGNOSTIC_TEST

Sponsors & collaborators

Chinese University of Hong Konglead sponsor

Mapped research locations

Hong KongHong Kong1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04992195 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.